Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunogenic cell death in cancer and infectious disease
Lorenzo Galluzzi, Aitziber Buqué, Oliver Kepp, et al.
Nature reviews. Immunology (2016) Vol. 17, Iss. 2, pp. 97-111
Closed Access | Times Cited: 2435

Showing 1-25 of 2435 citing articles:

Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
Lorenzo Galluzzi, Ilio Vitale, Stuart A. Aaronson, et al.
Cell Death and Differentiation (2018) Vol. 25, Iss. 3, pp. 486-541
Open Access | Times Cited: 5331
Natural products in drug discovery: advances and opportunities
Atanas G. Atanasov, Sergey B. Zotchev, Verena M. Dirsch, et al.
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 3, pp. 200-216
Open Access | Times Cited: 3450
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Jérôme Galon, Daniela Bruni
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 3, pp. 197-218
Closed Access | Times Cited: 2622
Biological Functions of Autophagy Genes: A Disease Perspective
Beth Levine, Guido Kroemer
Cell (2019) Vol. 176, Iss. 1-2, pp. 11-42
Open Access | Times Cited: 2273
Broadening horizons: the role of ferroptosis in cancer
Xin Chen, Rui Kang, Guido Kroemer, et al.
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 5, pp. 280-296
Closed Access | Times Cited: 2012
The molecular machinery of regulated cell death
Daolin Tang, Rui Kang, Tom Vanden Berghe, et al.
Cell Research (2019) Vol. 29, Iss. 5, pp. 347-364
Open Access | Times Cited: 1992
Dendritic cells in cancer immunology and immunotherapy
Stefanie K. Wculek, Francisco J. Cueto, Adriana M. Mujal, et al.
Nature reviews. Immunology (2019) Vol. 20, Iss. 1, pp. 7-24
Closed Access | Times Cited: 1978
The immune contexture in cancer prognosis and treatment
Wolf H. Fridman, Laurence Zitvogel, Catherine Sautès‐Fridman, et al.
Nature Reviews Clinical Oncology (2017) Vol. 14, Iss. 12, pp. 717-734
Closed Access | Times Cited: 1885
Inflammation and tumor progression: signaling pathways and targeted intervention
Huakan Zhao, Lei Wu, Guifang Yan, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1611
Cancer immunoediting and resistance to T cell-based immunotherapy
Jake S. O’Donnell, Michele W.L. Teng, Mark J. Smyth
Nature Reviews Clinical Oncology (2018) Vol. 16, Iss. 3, pp. 151-167
Closed Access | Times Cited: 1426
Gasdermin E suppresses tumour growth by activating anti-tumour immunity
Zhibin Zhang, Ying Zhang, Shiyu Xia, et al.
Nature (2020) Vol. 579, Iss. 7799, pp. 415-420
Open Access | Times Cited: 1278
Autophagy in major human diseases
Daniel J. Klionsky, Giulia Petroni, Ravi K. Amaravadi, et al.
The EMBO Journal (2021) Vol. 40, Iss. 19
Open Access | Times Cited: 1083
Therapeutic Targeting of the Tumor Microenvironment
Leire Bejarano, Marta Joana Costa Jordão, Johanna A. Joyce
Cancer Discovery (2021) Vol. 11, Iss. 4, pp. 933-959
Open Access | Times Cited: 1071
Mitochondrial metabolism and cancer
Paolo E. Porporato, Nicoletta Filigheddu, José Manuel Bravo‐San Pedro, et al.
Cell Research (2017) Vol. 28, Iss. 3, pp. 265-280
Open Access | Times Cited: 1051
Using immunotherapy to boost the abscopal effect
Wilfred Ngwa, Omoruyi Credit Irabor, Jonathan D. Schoenfeld, et al.
Nature reviews. Cancer (2018) Vol. 18, Iss. 5, pp. 313-322
Open Access | Times Cited: 1007
Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors
Lorenzo Galluzzi, Juliette Humeau, Aitziber Buqué, et al.
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 12, pp. 725-741
Closed Access | Times Cited: 1004
The P2X7 Receptor in Infection and Inflammation
Francesco Di Virgilio, Diego Dal Ben, Alba Clara Sarti, et al.
Immunity (2017) Vol. 47, Iss. 1, pp. 15-31
Open Access | Times Cited: 988
Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion
Suchit Jhunjhunwala, Christian Hammer, Lélia Delamarre
Nature reviews. Cancer (2021) Vol. 21, Iss. 5, pp. 298-312
Closed Access | Times Cited: 975
Ferroptosis, necroptosis, and pyroptosis in anticancer immunity
Rong Tang, Jin Xu, Bo Zhang, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 968
Advances in immunotherapy for hepatocellular carcinoma
Bruno Sangro, Pablo Sarobe, Sandra Hervás‐Stubbs, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 8, pp. 525-543
Open Access | Times Cited: 938
Targeting photodynamic and photothermal therapy to the endoplasmic reticulum enhances immunogenic cancer cell death
Wei Li, Jie Yang, Lihua Luo, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 903
Drug resistance and combating drug resistance in cancer
Xuan Wang, Haiyun Zhang, Xiaozhuo Chen
Cancer Drug Resistance (2019)
Open Access | Times Cited: 873
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
Lorenzo Galluzzi, Ilio Vitale, Sarah H. Warren, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 1, pp. e000337-e000337
Open Access | Times Cited: 849
Immunogenic cell stress and death
Guido Kroemer, Claudia Galassi, Laurence Zitvogel, et al.
Nature Immunology (2022) Vol. 23, Iss. 4, pp. 487-500
Open Access | Times Cited: 844
Plasma membrane changes during programmed cell deaths
Yingying Zhang, Xin Chen, Cyril Gueydan, et al.
Cell Research (2017) Vol. 28, Iss. 1, pp. 9-21
Open Access | Times Cited: 842
Page 1 - Next Page

Scroll to top